The Half-life can change, it depends on the the ty
Post# of 145222
https://aidsinfo.nih.gov/drugs/423/leronlimab/0/professional
Quote:
Half-life (T½): In a study of multiple subcutaneous (SC) doses of leronlimab in adults with HIV, the mean terminal half-lives were 3.4 days (162 mg dose) and 3.7 days (324 mg dose).8 In a study of single intravenous (IV) doses of leronlimab in adults with HIV, the mean terminal half-lives were 3.13 days (5 mg/kg dose) and 3.33 days (10 mg/kg dose).9
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)